Status:
COMPLETED
Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
40+ years
Brief Summary
This study is conducted in Europe. The aim of this observational study is to determine diabetes control improvement, during the third month of follow-up after insulin intensification to at least 3 dai...
Eligibility Criteria
Inclusion
- Type 2 diabetes patients
- Treatment with two insulin daily injections and needing insulin intensification regimen to at least three daily injections
- HbA1c greater than or equal to 8.0%
Exclusion
- Patients not performing glycaemia self-measurements
- Secondary diabetes
- Requirement of or use of an insulin pump
- Treatment with corticoids
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT00712478
Start Date
September 1 2007
End Date
March 1 2009
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Paris La Défense, France, 92936